// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
We live in an age where the use of computers and software systems are directly integrated into th
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis
By: Trish Li and Edith Chang